IP Library Granted Patent US 8,211,888
Granted Patent B2
US 8,211,888 · App. 13/174,091 · Granted Jul 3, 2012

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,211,888
App. No.
13/174,091
Granted
Jul 3, 2012
Kind
B2
Abstract

The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Claims (10)

1. A method for treating rheumatoid arthritis in a subject, comprising administering to the subject an effective amount of a compound according to the formula

or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein the compound or the pharmaceutically acceptable salt thereof is in the form of a hydrate.

3. The method of claim 2 , wherein the compound is a free acid.

4. The method of claim 2 , wherein the compound is a pharmaceutically acceptable salt.

5. The method of claim 4 , wherein the pharmaceutically acceptable salt is an alkali metal salt.

6. The method of claim 5 , wherein the pharmaceutically acceptable salt is a sodium salt.

7. The method of claim 6 , wherein the pharmaceutically acceptable salt is a disodium salt.

8. The method of claim 4 , wherein the pharmaceutically acceptable salt is an alkaline earth metal salt.

9. The method of claim 8 , wherein the pharmaceutically acceptable salt is a calcium salt.

Assignments (3)
SECURITY INTEREST Recorded May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2011
From: SINGH, RAJINDER; BHAMIDIPATI, SOMASEKHAR; MASUDA, ESTEBAN; SUN, THOMAS; STELLA, VALENTINO J.
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 026680/0035 →